Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Observe Medical ASA has the GF Score of 29, which implies that the company
might have
Worst future performance potential, or not enough data.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Observe Medical ASA
might have
Worst future performance potential, or not enough data.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Observe Medical ASA (STU:OM50) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Observe Medical ASA GF Score Related Terms
STU:OM50 vs ABT, SYK, MDT: GF Score Comparison
For the Medical Devices subindustry, Observe Medical ASA's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Observe Medical ASA GF Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Observe Medical ASA's GF Score distribution charts can be found below:
* The bar in red indicates where Observe Medical ASA's GF Score falls into.
Observe Medical ASA (STU:OM50) has a GF Score of 29 as of Jul. 18, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Observe Medical ASA and its competitors. This is near median its historical median of 32.00. Over the past decade, Observe Medical ASA's GF Score has ranged from 1.00 to 66.00.
Is Observe Medical ASA's GF Score too high?
Observe Medical ASA's current GF Score of 29 is near median its 10-year median of 32.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 66.00. Overall, Observe Medical ASA has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Observe Medical ASA's GF Score compare to ABT and SYK?
Observe Medical ASA's GF Score of 29 can be compared against companies in the Medical Devices & Instruments industry. Historically, Observe Medical ASA's own GF Score has ranged from 1.00 to 66.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Devices & Instruments company?
A good GF Score depends on the Medical Devices & Instruments industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Observe Medical ASA and its competitors. Observe Medical ASA's current GF Score is 29, which is near median its own 10-year median of 32.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Observe Medical ASA stock overvalued right now?
Observe Medical ASA (STU:OM50) has a current GF Score of 29. The stock's GF Value™ is €0.02, compared to a current price of €0.08 — trading 315% above its estimated fair value. The current GF Score is 29, which is near median its 10-year median of 32.00. Observe Medical ASA's overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Observe Medical ASA (STU:OM50), the current GF Score is 29 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Observe Medical ASA (STU:OM50) Overvalued in 2026?
Based on GuruFocus' analysis, Observe Medical ASA stock appears to be overvalued.
The current stock price of €0.08 is trading 315% above its estimated GF Value™ of €0.02.
Key valuation signals for STU:OM50:
GF Score: 29 (near median its 10-year median of 32.00)
GF Value™: €0.02 vs. price of €0.08 (315% above fair value)
No single metric tells the full story. See the STU:OM50 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Observe Medical ASA is a Nordic medtech company focused on the development, commercialization, and scaling of medical technologies for the healthcare markets. The company's portfolio of proprietary products consists of: Sippi, a CE marked digitalized system for urine output measurement, the UnoMeter portfolio consisting of manual urine output measurement products and solutions for measuring intra-abdominal pressure. The company operates internationally through subsidiaries in Norway, Sweden and Denmark.
29GF Score
Get the complete analysis for STU:OM50
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OM50 has been successfully added to your 
